Lehman David Aaron's Form 4 filing
Pulmonx Corp (LUNG) · filed Mar 5, 2025
- Accession no.
- 0001415889-25-007039
- Filed
- Mar 5, 2025
- Trade date
- Mar 3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $170.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lehman David AaronCIK 0001354228 | Officer (GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | SSaleDisposed | −669 | $7.14 | −$4,776.66 | 197,182 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −1,177 | $7.14 | −$8,403.78 | 196,005 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −4,490 | $7.14 | −$32,058.6 | 191,515 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −2,397 | $7.14 | −$17,114.58 | 189,118 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −13,622 | $7.97 | −$108,567.34 | 175,496 | Direct | |
| Mar 3, 2025 | Common Stock | AGrant or awardAcquired | +108,000 | $0.00 | $0 | 283,496 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.